certican 1 mg tablets
novartis pharma gmbh - Эверолимус - 1 mg tablets
certican 0,1 mg dispersible tablets
novartis pharma gmbh - Эверолимус - 0,1 mg dispersible tablets
certican 0,25 mg dispersible tablets
novartis pharma gmbh - Эверолимус - 0,25 mg dispersible tablets
kisplyx
eisai gmbh - ленавиниб месилат - Карцином, бъбречна клетка - Антинеопластични средства - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.